SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(von Kobyletzki Laura)
 

Sökning: WFRF:(von Kobyletzki Laura) > Validation of Patie...

Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases

Ortsäter, Gustaf (författare)
Quantify Research, Stockholm, Sweden,Quantify Res, Stockholm, Sweden.,Quantify Research AB
De Geer, Anna (författare)
Pfizer AB, Stockholm, Sweden.
Geale, Kirk (författare)
Umeå University,Umeå universitet,Dermatologi och venereologi,Quantify Research, Stockholm, Sweden,Quantify Res, Stockholm, Sweden.;Umeå Univ, Dept Publ Hlth & Clin Med, Dermatol & Venerol, Umeå, Sweden.
visa fler...
Rieem Dun, Alexander (författare)
Quantify Research, Stockholm, Sweden,Quantify Res, Stockholm, Sweden.,Quantify Research AB
Lindberg, Ingrid (författare)
Quantify Research, Stockholm, Sweden,Quantify Res, Stockholm, Sweden.,Quantify Research AB
Thyssen, Jacob P. (författare)
Department of Dermatology and Venerology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark,Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol & Venerol, Copenhagen, Denmark.
von Kobyletzki, Laura (författare)
Lund University,Lunds universitet,Yrkes- och miljödermatologi,Forskargrupper vid Lunds universitet,Occupational and Environmental Dermatology,Lund University Research Groups,Skåne University Hospital
Ballardini, Natalia (författare)
Karolinska Institute,Karolinska Institutet,Stockholm South General Hospital
Henrohn, D (författare)
Uppsala University,Uppsala universitet,Institutionen för medicinska vetenskaper,Pfizer AB, Stockholm, Sweden.
Neregård, Petra (författare)
Pfizer AB, Stockholm, Sweden.
Cha, Amy (författare)
Pfizer Inc, New York, United States,Pfizer Inc, New York, NY USA.
Cappelleri, Joseph C. (författare)
Pfizer Inc, New York, United States; Pfizer Inc, Groton, United States,Pfizer Inc, New York, NY USA.;Pfizer Inc, Groton, CT 06340 USA.
Neary, Maureen P. (författare)
Pfizer Inc, New York, United States; Pfizer Inc, Collegeville, United States,Pfizer Inc, New York, NY USA.;Pfizer Inc, Collegeville, PA USA.
visa färre...
Quantify Research, Stockholm, Sweden Quantify Res, Stockholm, Sweden (creator_code:org_t)
2022-01-18
2022
Engelska.
Ingår i: Dermatology and Therapy. - : Adis. - 2193-8210 .- 2190-9172. ; 12, s. 545-559
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Introduction: The use of real-world data offers a possibility to perform large-scale epidemiological studies in actual clinical settings. Despite their many advantages, administrative databases were not designed to be used in research, and the validation of diagnoses and treatments in administrative databases is needed. The primary objective of this study was to validate an existing algorithm based on dispensed prescriptions and diagnoses of skin conditions to identify pediatric patients with atopic dermatitis (AD), using a diagnosis of AD in primary care as a gold standard.Methods: Retrospective observational data were collected from nation-wide secondary care and pharmacy-dispensed medication databases and two regional primary care databases in Sweden. An existing algorithm and a Modified algorithm, using skin-specific diagnoses from secondary care and/or pharmacy-dispensed prescriptions to identify patients with AD, were assessed. To verify the presence of AD, diagnoses from primary care were used in the base case and complemented with diagnoses from secondary care in a sensitivity analysis.Results: The sensitivity (30.0%) and positive predictive value (PPV) (40.7%) of the existing algorithm were low in the pediatric patient population when using primary care data only but increased when secondary care visits were also included in the Modified algorithm (sensitivity, 62.1%; PPV, 66.3%). The specificity of the two algorithms was high in both the base case and sensitivity analysis (95.1% and 94.1%). In the adult population, sensitivity and PPV were 20.4% and 8.7%, respectively, and increased to 48.3% and 16.9% when secondary care visits were also included in the Modified algorithm.Conclusion: The Modified algorithm can be used to identify pediatric AD populations using primary and secondary administrative data with acceptable sensitivity and specificity, but further modifications are needed to accurately identify adult patients with AD.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Dermatologi och venereologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Dermatology and Venereal Diseases (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Allmänmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- General Practice (hsv//eng)

Nyckelord

Atopic dermatitis
Patient identification
Primary care
Validation
dermatologi och venereologi
Dermatology and Venerology
Atopic dermatitis
Patient identification
Primary care
Validation

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy